Celiac disease
Clinical trials for Celiac disease explained in plain language.
Never miss a new study
Get alerted when new Celiac disease trials appear
Sign up with your email to follow new studies for Celiac disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill shield celiac patients from accidental gluten?
Disease control CompletedThis study tested whether the drug ritlecitinib could prevent intestinal damage and symptoms when people with celiac disease ate gluten. 62 adults with well-controlled celiac disease (on a gluten-free diet) took either the drug or a placebo along with a daily gluten challenge. Th…
Matched conditions: CELIAC DISEASE
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a probiotic help celiac hearts? new study explores cholesterol reduction
Disease control CompletedThis study looked at whether a probiotic called LP-LDL can lower cholesterol and improve heart health in adults with celiac disease. 50 participants took the probiotic to see if it reduced their cholesterol levels and body mass index. The goal was to find a safe way to manage hea…
Matched conditions: CELIAC DISEASE
Sponsor: University of Roehampton • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New infusion could shield celiac patients from gluten accidents
Disease control CompletedThis Phase 2 trial tested whether TAK-101, given as an intravenous infusion, can reduce gluten-related symptoms and immune activation in adults with well-controlled celiac disease who follow a gluten-free diet. Participants received two doses of TAK-101 or placebo, and all were l…
Matched conditions: CELIAC DISEASE
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug may shield celiac patients from gluten damage
Disease control CompletedThis study tested a drug called KAN-101 in 55 adults with celiac disease who had been on a gluten-free diet for at least a year. Participants received either KAN-101 or a placebo, then underwent a two-week gluten challenge. The drug appeared to reduce gluten-induced damage to the…
Matched conditions: CELIAC DISEASE
Phase 2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a simple infusion let celiac patients eat gluten again?
Disease control CompletedThis study tested a new drug called TPM502 in 28 adults with celiac disease. The goal was to see if two infusions of TPM502 could safely train the immune system to tolerate gluten, potentially reducing the need for a lifelong gluten-free diet. Participants received either TPM502 …
Matched conditions: CELIAC DISEASE
Phase 2 • Sponsor: Topas Therapeutics GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New oral diagnostic for celiac disease passes first safety check
Diagnosis CompletedThis early-stage study tested whether a single oral dose of HB-2121 is safe in adults. Researchers monitored 18 participants for side effects and tracked how the drug moves through the body over 30 days. The goal is to develop a new way to diagnose celiac disease.
Matched conditions: CELIAC DISEASE
Phase 1 • Sponsor: Nielsen Fernandez-Becker • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Could A2 milk ease gut symptoms in teens with celiac disease?
Symptom relief CompletedResearchers are testing whether milk and dairy products made with A2 beta-casein protein can improve gut symptoms, quality of life, sleep, and nutritional blood markers in adolescents with celiac disease. The trial enrolls 50 teens aged 10 to 18 who were diagnosed with celiac dis…
Matched conditions: CELIAC DISEASE
Sponsor: Halic University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New app aims to boost quality of life for celiac patients
Symptom relief CompletedThis study tests whether a mobile app, supported by a nurse, can improve quality of life for adults newly diagnosed with celiac disease. Sixty participants will either use the app for six months or receive standard education. The goal is to see if the app helps with diet adherenc…
Matched conditions: CELIAC DISEASE
Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Low-FODMAP diet offers hope for celiac sufferers with ongoing gut pain
Symptom relief CompletedThis study looked at whether cutting out certain carbs (FODMAPs) can help people with celiac disease who still have stomach issues even after following a gluten-free diet. Researchers surveyed and then ran a controlled trial with 80 adults who had celiac disease and irritable bow…
Matched conditions: CELIAC DISEASE
Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a new oat variety be safe for celiac patients?
Symptom relief CompletedThis study tested whether a low-immunogenic oat variety called Saul is well-tolerated by adults with celiac disease who are in remission. Forty participants ate 50 grams of gluten-free Saul oat flakes daily for 14 days. Researchers tracked symptoms and blood markers to see if the…
Matched conditions: CELIAC DISEASE
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New hope for celiac sufferers: drug targets stubborn symptoms
Symptom relief CompletedThis study tested a drug called PRV-015 in 388 adults with celiac disease who still had symptoms like belly pain and bloating even after following a strict gluten-free diet. The goal was to see if the drug could reduce these symptoms better than a placebo. Participants took the d…
Matched conditions: CELIAC DISEASE
Phase 2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Scientists hunt for hidden triggers of autoimmune diseases
Knowledge-focused CompletedThis study collects tissue and blood samples from 300 people with autoimmune diseases like Crohn's, multiple sclerosis, and celiac disease. Researchers aim to identify the specific targets of immune cells (T cells) that cause inflammation. The goal is to discover new targets for …
Matched conditions: CELIAC DISEASE
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Massive spanish study maps celiac disease trends across generations
Knowledge-focused CompletedThis completed study looked at how common celiac disease is in Spain and what factors might influence it. Researchers tested nearly 5,000 people of all ages across five regions using blood tests and biopsies. They aimed to understand why earlier studies found different rates in c…
Matched conditions: CELIAC DISEASE
Sponsor: Hospital Mutua de Terrassa • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Capsule camera study: is prep worth it?
Knowledge-focused CompletedThis study looked at whether taking a bowel-cleaning liquid before a capsule endoscopy helps doctors see the small intestine better and find more problems. 230 adults scheduled for the procedure were randomly assigned to get either a split dose, a single morning dose, or no speci…
Matched conditions: CELIAC DISEASE
Phase 4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New gluten challenge study aims to make 'Gluten-Free' labels safer
Knowledge-focused CompletedThis completed study from Oslo University Hospital involved 33 adults with celiac disease who followed a strict gluten-free diet. Over five separate one-day challenges, participants consumed wheat gluten, barley gluten, hydrolyzed barley gluten, or a placebo. Researchers measured…
Matched conditions: CELIAC DISEASE
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Kids' laxative study reveals how body handles the drug
Knowledge-focused CompletedThis study measured levels of the laxative PEG 3350 and its breakdown products in the blood and urine of 158 children who were already taking it, compared to children not taking it. The goal was simply to learn how the body processes this medicine, not to change any treatments. R…
Matched conditions: CELIAC DISEASE
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC